Drugs / IPOVAC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02775942 | Nov 2015 → Jul 2016 | poliomyelitis | National Institute of Hygiene and Epidemiology, Vietnam | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IPOVAC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02775942 ↗ |
| Known as | IPOVAC- POLYVAC-Vietnam | “A dose escalating study with 3 different dosing regimens of the studied vaccine (IPOVAC- POLYVAC-Vietnam) and a licensed vaccine (IMOVAC-Sanofi Pasteur- France) is conducted in...” NCT02775942 ↗ |
| Modality | Vaccine | “the studied vaccine (IPOVAC- POLYVAC-Vietnam)” NCT02775942 ↗ |
| Route | Subcutaneous | “Subcutaneous inj 0.5ml/dose” NCT02775942 ↗ |